AVDL
Avadel Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.64 / 10
Netural
The fund flow profile scores 7.28/10, demonstrating robust fund flow characteristics. Favorable Small movements are tempered by challenging overall, block, Medium, Large, and Extra-large dynamics, supporting positive flow assessment. Analyst coverage indicates divided analyst consensus with neutral perspective.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-20
InstitutionWells Fargo
Times predicted3
Historical Win Rate0.0%
Is money flowing into or out of AVDL?
- AVDL holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.64/10 (Netural).
